Severe villus atrophy and chronic malabsorption induced by azathioprine

Gastroenterology

Volumn 124, Issue 7, 2003, Pages 1950-1957

  Ziegler, Thomas R ^a   Fernández Estívariz, Concepción ^a   Gu, Li H ^a   Fried, Michael W ^b   Leader, Lorraine M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DIPEPTIDYL PEPTIDASE IV; MESSENGER RNA; PANCREAS ENZYME; PREDNISONE; TRACE ELEMENT;

ADULT; ARTHRITIS; ARTICLE; AUTOIMMUNE HEPATITIS; BONE MARROW DEPRESSION; CASE REPORT; CHOLECYSTITIS; CHRONIC DIARRHEA; CHRONIC DISEASE; DISEASE SEVERITY; DRUG WITHDRAWAL; DUODENUM MUCOSA; ENTERITIS; FEVER; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUTEN FREE DIET; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTESTINE BIOPSY; INTESTINE BRUSH BORDER; INTESTINE VILLUS ATROPHY; LEUKOPENIA; LIVER FUNCTION TEST; MALABSORPTION; MALE; NAUSEA; PANCREATITIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CALORIE MALNUTRITION; RASH; SEPSIS; VEIN THROMBOSIS; VOMITING;

EID: 0037606066     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00405-0     Document Type: Article

References (24)

1. Pisetsky DS, St Clair EW. Progress in the treatment of rheumatoid arthritis. JAMA 2001;286:2787-2790.
2. Whisnant JK, Pelkey J. Rheumatoid arthritis: treatment with azathioprine (Imuran®). Clinical side-effects and laboratory abnormalities. Ann Rheum Dis 1982;41(Suppl 1):44-47.
3. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-963.
4. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180-188.
5. Present DH. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis. Gastroenterol Clin North Am 1989;18:57-71.
6. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;123:132-142.
7. Sandborn WJ. Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol 1998;225(Suppl):92-99.
8. Lamers CB, Griffioen G, van Hogezand RA, Veenendaal RA. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease. Scand J Gastroenterol 1999;230(Suppl): 111-115.
9. Boulton-Jones JR, Pritchard K, Mahmoud AA. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Aliment Pharmacol Ther 2000;14: 1561-1565.
10. Lowry PW, Franklin CL, Weaver AL, Pike MG, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut 2001;49:665-670.
11. Czaja AJ. Autoimmune liver disease. In: Zakim DM, Boyer TD, eds. Hepatology: a textbook of liver disease. Volume 4. Philadelphia, PA: Saunders, 2003:1163-1202.
12. Assini JF, Hamilton R, Strosberg JM. Adverse reactions to azathioprine mimicking gastroenteritis. J Rheumatol 1986;13: 1117-1118.
13. Godeau B, Paul M, Autegarden JE, Leynadier F, Astier A, Schaeffer A. Hypersensitivity to azathioprine mimicking gastroenteritis. Absence of recurrence with 6-mercaptopurine. Gastroenterol Clin Biol 1995;19:117-119.
14. Keystone EC, Schabas R. Hypotension with oliguria: a side-effect of azathioprine. Arthritis Rheum 1981;24:1453-1454.
15. Marbet U, Schmid I. Severe life-threatening diarrhea caused by azathioprine but not by 6-mercaptopurine. Digestion 2001;63: 139-142.
16. Cox J, Daneshmend TK, Hawkey CJ, Logan RFA, Walt RP. Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease. Gut 1988;29:686-688.
17. Adibi SA. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 1997;113:332- 340.
18. Darmoul D, Voisin T, Couvineau A, Rouyer-Fessard C, Salomon R, Wang Y, Swallow DM, Laburthe M. Regional expression of epithelial dipeptidyl peptidase IV in the human intestines. Biochem Biophys Res Commun 1994;203:1224-1229.
19. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, Trugnan G. Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem 1992;267:4824-4833.
20. Ziegler TR, Fernandez-Estivariz C, Gu LH, Bazargan N, Umeakunne K, Wallace TM, Diaz EE, Rosado KE, Pascal RR, Galloway JR, Wilcox JN, Leader LM. Distribution of the H+/ peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome. Am J Clin Nutr 2002;75:922-930.
21. Riedel RR, Schmitt A, de Jonge JP, Hartmann A. Gastrointestinal type 1 hypersensitivity to azathioprine. Klin Wochenschr 1990; 68:50-52.
22. Egger G, Ackman D. Light microscopic examination of the jejunum after long-standing azathioprine treatment. Experientia 1971;27:326.
23. Paimela H, Hockerstedt K, von Numers H, Ahonen J. Short-term high-dose corticosteroids and gastroduodenal mucosa. A prospective clinical study on renal transplant recipients. Transpl Int 1990;3:62-65.
24. Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, Lenzi M, Bianchi FB, Czaja AJ. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998;43:2190-2195.